Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma

Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinomaAnti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma, Published online: 05 January 2018; doi:10.1038/s41419-017-0029-0Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma

Source: Cell death and disease - January 5, 2018 Category: Internal Medicine Authors: Nathan Redlich Anthony M. Robinson Kwangok P. Nickel Andrew P. Stein Deric L. Wheeler Douglas R. Adkins Ravindra Uppaluri Randall J. Kimple Brian A. Van Tine Loren S. Michel Source Type: research